Skip to content
Recall Observatory FDA recall evidence

Drug product

Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04

D-0278-2025

March 07, 2025

Class II

Product summary

Firm
Slate Run Pharmaceuticals
Event
Event 96433
Status
Completed
Classification
Class II
Quantity
56,790 bottles
Official record key
drug-enforcement:D-0278-2025

Official wording

Reason: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

Code information: Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026

Distribution pattern: Product was distributed to 8 distributors who may have further distribute the product nationwide.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    nitrosamine impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP deviations